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Abstract
Background Bariatric surgery has been reported to be an
effective treatment for obstructive sleep apnea (OSA).
However, this evidence was not enough for different popula-
tions. Thus, we conducted a follow-up study to evaluate the
effect of bariatric surgery on OSA in a Chinese population
with obesity and type 2 diabetes mellitus (T2DM).
Methods From May 2011 to March 2014, 72 consecutive
subjects with obesity and T2DMwere recruited for this study.
Before and at least 6 months after the laparoscopic Roux-en-Y
gastric bypass (LYGB) surgery, all subjects were asked to
undergo a polysomnography test. During the sleep center
visit, anthropometric characteristic data, blood samples, and
sleep questionnaires were collected.
Results In total, 44 Chinese participants with OSA were in-
cluded in the study. Compared with baseline data, the postop-
erative anthropometric characteristics, blood measurements,
and sleep recording data, such as weight, apnea hypopnea
index (AHI), and insulin resistance index, differed significant-
ly (p<0.001). The change in AHI was correlated significantly
with preoperative weight (r=0.298, p<0.05), preoperative
AHI (r=0.729, p<0.001), preoperative waist circumference
(r=0.307, p<0.05), and preoperative insulin resistance (IR)
index (r=−0.301, p<0.05). Postoperative AHI was correlated
significantly with age (r=0.039, p=0.039) and preoperative
AHI (r=0.445, p=0.002), and the following prediction model
was generated: log10 (postoperative AHI)=0.626×log10 (pre-
operative AHI) +0.010×age −0.581.
Conclusions Our findings indicate that LYGB could be an
effective therapeutic intervention in the management of OSA
for patients with both obesity and T2DM, and the preoperative
AHI and age might be important factors that influence the
effort of LYGB.
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Introduction
Obstructive sleep apnea (OSA) is one of the most common
sleep disturbances; it affects 3.2–20 % of the adult population
[1, 2] and has a negative impact on public health, increasing
both morbidity and mortality [3]. Although continuous posi-
tive airway pressure (CPAP), oral appliances, and surgical
modifications of the airway are considered parts of the routine
management of patients with OSA, there remain many prob-
lems with these treatments in practice. Nasal CPAP is consid-
ered the gold standard therapy for OSA [4]. However, report-
ed CPAP compliance rates vary from 34 to 85 % [5, 6], which
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might limit the therapeutic value for OSA patients over the
long term. Oral appliances are generally viewed as being less
efficacious than treatment with CPAP [7, 8]. Moreover, 6–
86 % of patients who used oral appliances have been reported
to experience adverse effects, including dryness of the tongue
and throat, pain in the teeth and jaw, and insomnia [7, 9].
Various surgical techniques of the upper airway have been
used to treat OSA, although the use of surgery for this condi-
tion remains somewhat controversial and is associated with
limited and unpredictable efficacy that may diminish over the
long term [10–12]. That is, although several treatments exist,
they are often poorly tolerated or only partially alleviate the
abnormalities. Thus, there is a need to improve patient adher-
ence to existing treatments and to develop new treatments.
Bariatric surgery, which is currently the most effec-
tive treatment for morbid obesity, has been reported as a
novel therapeutic treatment option for OSA [13]. The
effect of bariatric surgery on OSA has been reported to
be encouraging [14, 15]. However, these published se-
ries have not included diverse populations, especially in
developing countries. Moreover, whether bariatric surgery is
applicable to patients with OSA and other complications, such
as obesity and type 2 diabetes mellitus (T2DM), should be
determined.
Given the significant morbidity and mortality associ-
ated with OSA and the potential therapeutic value of
bariatric surgery, we conducted a follow-up study of the
effect of laparoscopic Roux-en-Y gastric bypass (LYGB)




From May 2011 to March 2014, 72 consecutive subjects with
obesity and T2DM, who chose to be treated with LYGB
surgery in our hospital, were recruited for this study. The
diagnostic criterion for obesity [16] was a body mass index
(BMI) of 25 kg/m2. The diagnosis of T2DMwas based on the
1999World Health Organization criteria [17]. All participants
were aged 20–70 years. Patients with psychiatric disturbances
and those undergoing systemic steroid treatment or hormone
replacement therapy were excluded.
All participants provided written informed consent. This
study was approved by the Ethics Committee of the Shanghai
Jiao Tong University Affiliated Sixth People’s Hospital and
complied with the Declaration of Helsinki.
Before and at least 6 months after the LYGB surgery, all
subjects were asked to undergo an overnight PSG test in the
sleep center at our hospital. During the sleep center visit, all
participants were asked to report whether the witnessed apnea
exist and completed the Epworth Sleepiness Scale (ESS)
questionnaire before the overnight PSG test. Fasting blood
samples were taken the next morning for measurement of
glucose and insulin concentrations. Body habitus, including
weight, height, neck circumference (NC), waist circumference
(WC), and hip circumference (HC), was measured using
standard anthropometric methods.
Polysomnography and Definitions
A laboratory-based PSG (Alice 4: Respironics Inc.,
Pittsburgh, USA) was used to diagnose OSA. PSG records
were staged manually according to standard criteria by the
same skilled technician. Respiratory events were scored ac-
cording to the American Academic Sleep Medicine (AASM)
criteria [18]. The apnea hypopnea index (AHI) was defined as
the number of events of apnea and hypopnea per hour during
sleep. The parameters of mean oxygen saturation (mean
SaO2), minimum SaO2, the percentage of time spent at an
SaO2 of <90 % (CT90%), oxygen desaturation index (ODI),
and arousal index were also included in the data anal-
ysis. Patients with AHI of <5 events/h before LYGB
surgery were excluded from the follow-up study. Based
on the second PSG test, patients with postoperative AHI
of <5 events/h were considered the “cured” group, and
those with postoperative AHI of <20 events/h combined
with >50 % reduction from baseline were considered the
“improved” group.
Fig. 1 Flow diagram of recruitment of participants. AHI apnea
hypopnea index, BMI body mass index, LYGB laparoscopic Roux-en-Y
gastric bypass
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Statistical Analysis
Continuous variables are presented as means (standard devi-
ation), except for skewed variables, which are presented as
medians (interquartile range). Categorical variables are
expressed as percentages. Differences between baseline and
postoperative characteristics of the participants were exam-
ined using a paired Student’s t test, the Wilcoxon signed rank
test, the Kruskal-Wallis test, or the χ2 test, as appropriate.
Correlations between the various variables and PSG parame-
ters were analyzed using Spearman’s correlation test.
Parameters that might influence the effect of LYGB surgery
on OSA were evaluated by linear regression analysis, with
skewed data transformed into normality. We considered
p values <0.05 to indicate statistical significance for a two-
sided test. All statistical analyses were performed using the
SPSS software (ver. 13.0.0 for Windows; SPSS Inc., Chicago,
IL, USA).
Results
In total, 72 Chinese patients with obesity and T2DM were
recruited for the study. After the first PSG test, 18 subjects
were excluded because of AHI <5. The remaining 54 patients
with T2DM and OSA were included in the follow-up study.
All participants were asked to undergo a second PSG test at
least 6 months after surgery. However, ten patients were
excluded because of lost to follow-up, or refusing to take the
second PSG test (Fig. 1). However, the anthropometric data
and sleep recording data from their first visit were similar
(p>0.05) to those of the remaining 44 patients. There were
26 (59.1 %) females and 18 (40.9 %) males in the study, aged
from 24 to 66 years. The time between the two visits
ranged from 6.0 to 24.7 months. Patient demographics are
shown in Table 1. The LYGB surgeries were performed by the
same team. No adverse event attributable to the LYGB surgery
was recorded.
Anthropometric Characteristic Data and Blood Parameters
During the follow-up, the mean change in weight was −18.4 kg
(95 % confidence interval [CI], −20.4 to −16.4), and the mean
change in BMI was −6.7 kg/m2 (95 % CI, −7.4 to −5.9). The
prevalence of severe obesity (BMI≥30 kg/m2) in the study was
52.3 % at baseline and 2.3 % after the operation. The other





a Paired Student’s t test for
?equivalence between groups or
Wilcoxon signed rank test for
skewed data between groups
Characteristic Preoperative (SD) Postoperative (SD) Mean difference (95 % CI) p Valuea
Weight (kg) 86.3 (12.7) 67.9 (10.7) −18.4 (−20.4 to −16.4) <0.001
BMI (kg/m2) 31.1 (3.4) 24.4 (2.6) −6.7 (−7.4 to −5.9) <0.001
NC (cm) 39.6 (2.9) 35.1 (3.4) −4.5 (−5.3 to −3.7) <0.001
WC (cm) 105.0 (9.6) 87.7 (9.0) −17.4 (−19.8 to −15.0) <0.001
HC (cm) 108.1 (8.6) 95.4 (6.8) −12.6 (−14.5 to −10.8) <0.001
W/H ratio 0.97 (0.05) 0.92 (0.07) −0.05 (−0.07 to −0.03) <0.001
AHI (/h) 22.4 (17.8) 7.1 (9.4) −15.4 (−20.3 to −10.4) <0.001
Apnea index (/h) 10.1 (13.4) 4.4 (8.0) −5.7 (−9.7 to −1.8) 0.001
Hypopnea index (/h) 12.3 (9.7) 2.7 (3.2) −9.7 (−12.6 to −6.7) <0.001
Mean SaO2 (%) 93.4 (2.9) 95.5 (1.7) 4.3 (−1.7 to 10.4) <0.001
Minimum SaO2 (%) 77.1 (11.9) 86.7 (6.7) 10.8 (5.7 to 15.8) <0.001
CT90% (%) 8.0 (12.7) 1.4 (3.2) −6.7 (−10.4 to −2.9) <0.001
ODI (events/h) 25.4 (18.6) 6.4 (9.0) −17.8 (−22.9 to −12.7) <0.001
Arousal index (/h) 19.8 (13.5) 18.0 (13.4) −1.4 (−6.0 to 3.2) 0.163
ESS 6.8 (4.7) 3.0 (2.7) −3.8 (−5.1 to −2.6) <0.001
Glucose (mmol/L) 8.2 (2.5) 5.7 (1.2) −2.5 (−3.2 to −1.9) <0.001
Insulin (uU/mL) 20.6 (17.2) 7.3 (4.9) −13.3 (−17.8 to −8.8) <0.001
IR index 1.75 (0.71) 0.46 (0.59) −1.30 (−1.47 to −1.13) <0.001
Table 1 Overview of the study information
Characteristic Number (%) Mean±SD Range
Total number of patient 44
Male 18 (40.9)
Female 26 (59.1)
Cured group 28 (63.6)
Improved group 35 (79.5)
Height (m) 1.67±0.08 1.53–1.84
Preoperative weight (kg) 83.3±12.7 67.0–131.0
Age (years) 48±11 24–66
Length of follow-up (months) 9.7±5.5 6.0–24.7
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measurements of variables at baseline and at the second visit
are shown in Table 2. The changes in all of these parameters
were significant (p<0.001).
Effect of LYGB on OSA
The mean AHI value was 22.4 events/h (95 % CI, 17.0 to
27.9) at baseline and 7.1 events/h (95 % CI, 4.2 to 9.9) at the
second visit. The mean change in AHI was −15.4 events/h
(95 % CI, −10.4 to −20.3). The preoperative PSG test showed
that 22 patients had mild OSA (5≤AHI≤15 events/h), 9 had
moderate OSA (15<AHI≤30 events/h), and 13 had severe
OSA (AHI>30 events/h). During the follow-up period, 28
(63.6 %) patients were cured of OSA and 35 (79.5 %) patients
were improved significantly. The proportions of the mild,
moderate, and severe OSA cases who were cured compared
to baseline were 77.3, 55.6, and 46.2 %, respectively. The
corresponding improved ratios were 77.3, 77.8, and 84.6 %,
respectively. The nocturnal oxygen parameters, i.e., mean
SaO2, minimum SaO2, CT90%, and ODI, were also changed
significantly (p≤0.001). However, the arousal index did not
show a meaningful change (p=0.163). Meanwhile, the report-
ed ratio of witnessed apnea and the ESS score also declined
significantly (p<0.001).
By Spearman’s rank correlation analysis, the change in AHI
was found to be correlated significantly with preoperative
Fig. 2 Trends in the change inAHI according to preoperativeweight,WC,AHI, and IR index. AHI apnea hypopnea index,WCwaist circumference, IR
index insulin resistance index
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weight (r=0.298, p<0.05), preoperative AHI (r=0.729,
p<0.001), preoperative WC (r=0.307, p<0.05), and preopera-
tive insulin resistance (IR) index (r=−0.301, p<0.05; Fig. 2). In
addition to these four parameters, we included gender, age,
preoperative BMI, change in BMI, weight reduction, and du-
ration of follow-up to identify other factors associated with the
change in AHI, the cured ratio, and the improved ratio. As
shown in Table 3, the mean AHI value was significantly
reduced in the severe OSA group (p<0.001). The cured ratio
showed a downward trend according to increasing AHI, al-
though this was not statistically significant (p=0.15).
Moreover, no difference was found between the other groups
in the change in AHI, the cured ratio, or the improved ratio.
We compared the characteristics between the cured and
uncured groups and the improved and unimproved groups.
As shown in Table 4, the preoperative AHI was lower in the
cured group (p=0.012); however, the values of the mean
change in AHI were similar between the two groups
(p=0.494). The percent change of AHI was significantly
different between the cured group and uncured group
(p<0.001) (Supplementary Table 1). In contrast, the preoper-
ative AHI values were similar (p=0.749), and the mean
changes in AHI were significantly different (p<0.001) be-
tween the improved and unimproved groups (Supplementary
Table 2), while the percent change of AHI was significantly
different (p<0.001) (Supplementary Table 3).
When transformed to normality, the postoperative
AHI value was correlated significantly with age (r=0.039,
p=0.039) and preoperative AHI (r=0.445, p=0.002). By
linear regression analysis, we generated a model to predict
the postoperative AHI: log10(postoperative AHI)=0.626×
log10(preoperative AHI) +0.010×age −0.581. As shown in
Fig. 3, the predictive postoperative AHI was roughly consis-
tent with the trend in the actual postoperative AHI (r2=0.244,
p=0.001); no significant difference was found between the
actual value and the predictive value of the postoperative AHI
(p=0.870).
Discussion
In this follow-up study of 44 OSA patients with obesity and
T2DM, the total cured ratio and improved ratio of OSA after
LYGB surgery were 63.6 and 79.5 %. The cured ratios after
surgery in those with mild, moderate, and severe OSA at
baseline were 77.3, 55.6, and 46.2 %, respectively. The cor-
responding improved ratios were 77.3, 77.8, and 84.6 %,
respectively. These results indicate that LYGB surgery may be
an effective treatment for OSA patients with obesity and
T2DM.
Obesity is a known risk factor for the development of OSA
[19]. Many studies have been performed to evaluate the effect
of bariatric surgery in the treatment of OSA. However, al-
though benefits of bariatric surgery in OSA have been report-
ed, there is no recommendation for this procedure to be
included in the clinical guidelines for the treatment of OSA,
Table 3 Comparison of the changes of AHI between different groups
Groupa Number Change of AHI (95 % CI) Number of cured Number of improved
Female 26 −13.1 (−18.7 to −7.4) 16 (61.5 %) 20 (76.9 %)
Male 18 −18.7 (−28.0 to 9.4) 12 (66.7 %) 15 (83.3 %)
Age <40 years 9 −13.3 (−22.3 to −4.4) 8 (88.9 %) 8 (88.9 %)
Age ≥40 years 35 −15.9 (−21.8 to −10.0) 20 (57.1 %) 27 (77.1 %)
PRE-BMI <30.0 kg/m2 22 −12.5 (−19.2 to −5.9) 15 (68.2 %) 17 (77.3 %)
PRE-BMI ≥30.0 kg/m2 22 −18.2 (−25.8 to −10.6) 13 (59.1 %) 18 (81.8 %)
Mild OSA at baseline 22 −5.15 (−7.0 to −3.3)b 17 (77.3 %) 17 (77.3 %)
Moderate OSA at baseline 9 −15.5 (−20.1 to −10.8) 5 (55.6 %) 7 (77.8 %)
Severe OSA at baseline 13 −32.6 (−44.2 to −21.0) 6 (46.2 %) 11 (84.6 %)
PRE-IR index <1 6 −14.1 (−28.1 to −0.1) 4 (66.7 %) 5 (83.3 %)
PRE-IR index ≥1 38 −15.6 (−21.1 to −10.1) 24 (63.2 %) 30 (78.9 %)
Follow-up <1 year 31 −16.4 (−23.2 to −9.7) 20 (64.5 %) 25 (80.6 %)
Follow-up ≥1 year 13 −12.8 (−18.4 to −7.2) 8 (61.5 %) 10 (76.9 %)
a The patients were divided into mild OSA group (5≤AHI≤15 events/h), moderate OSA group (15<AHI≤30 events/h), and severe OSA group (AHI>
30 events/h), based on the preoperativeAHI. And, the participants were divided into nonsevere obesity group (BMI<30 kg/m2 ) and severe obesity group
(BMI≥30 kg/m2 ), based on the preoperative BMI. The dividing line was set 40 years for age, 1 for IR index, and 1 year for the follow-up visit. The other
parameters were grouped according to the median value
b The mean change of AHI was significant among mild OSA group, moderate OSA group, and severe OSA group, p value <0.001 with
Kruskal-Wallis test
AHI apnea hypopnea index, PRE preoperative, BMI body mass index, OSA obstructive sleep apnea, WC waist circumference, IR insulin resistance
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because studies in sufficiently diverse populations have not
been conducted to date, and there is not yet enough evidence
to recommend bariatric surgery for treating patients with both
OSA and T2DM [20]. Thus, in our study, we focused on the
effects of LYGB surgery in a Chinese obesity population with
both OSA and T2DM; the outcomes supported the therapeutic
efficacy of bariatric surgery in such patients, with 63.6 % of
the OSA patients showing resolution and 79.5 % showing
significant improvement, similar to a previous report [21].
Moreover, obese patients with severe OSA got more AHI
reduction from weight loss than those with only mild or
moderate disease (Table 3), consistent with Johansson et al.
[22] and Foster et al. [23]. Additionally, the generated predic-
tion model for postoperative AHI might provide a reference
Fig. 3 Actual and predicted
postoperative AHI values.
AHI apnea hypopnea index,
Post-AHI postoperative AHI
Table 4 Comparisons of data between the cured group and the uncured group
Parameters Cured group (n=28) Uncured group (n=16) p valueb p valuec
PRE (SD) POST (SD) Mean difference (95 % CI) PRE (SD) POST (SD) Mean difference (95 % CI)
Total AHI 17.6 (14.9) 2.0 (1.4)a −15.6 (−21.4 to −9.9) 30.8 (19.8) 15.9 (11.0)a −14.9 (−25.0 to −4.9) 0.012 0.494
Age 45.6 (11.8) 46.4 (11.9) 0.8 (0.6 to 1.0) 52.1 (8.6) 52.8 (8.6) 0.8 (0.6 to 1.0) 0.063 0.922
Weight 86.1 (14.1) 67.4 (11.4)a 18.8 (−21.6 to −16.0) 86.6 (10.1) 68.9 (9.6)a −17.7 (−20.6 to −14.9) 0.912 0.608
BMI 30.9 (3.5) 24.1 (2.5)a −6.8 (−7.8 to −5.8) 31.4 (3.4) 24.9 (2.8)a −6.5 (−7.5 to −5.4) 0.656 0.671
NC 39.1 (2.8) 35.0 (3.3)a −4.1 (−5.2 to −3.1) 40.5 (2.9) 35.4 (3.7)a −5.1 (−6.4 to −3.8) 0.187 0.239
WC 103.4 (9.4) 86.6 (9.1)a −16.9 (−20.1 to −13.6) 107.9 (9.7) 89.6 (8.9)a −18.3 (−22.2 to −14.3) 0.150 0.572
HC 107.0 (8.2) 95.0 (6.1)a −12.0 (−14.4 to −9.5) 109.9 (9.3) 96.1 (8.1)a −13.8 (−17.0 to −10.7) 0.297 0.350
Glucose 7.9 (2.3) 5.6 (1.2)a −2.3 (−3.1 to −1.5) 8.9 (2.6) 6.0 (1.1)a −2.9 (−4.2 to −1.6) 0.242 0.388
Insulin 19.7 (14.6) 7.2 (5.0)a −12.4 (−17.4 to −7.5) 22.3 (21.4) 7.5 (4.8)a −14.8 (−24.4 to −5.2) 0.981 0.884
IR 1.7 (0.7) 0.4 (0.6)a −1.3 (−1.5 to −1.1) 1.8 (0.8) 0.5 (0.6)a −1.3 (−1.7 to −1.0) 0.522 0.799
a Comparisons between the preoperative and postoperative parameters in the cured group or uncured group
b Comparisons of the preoperative parameters between the cured group and uncured group
c Comparisons between the mean differences of the parameters of the cured group and uncured group
PRE preoperative, POST postoperative, AHI apnea hypopnea index,AI apnea index,HI hypopnea index, BMI bodymass index,NC neck circumference,
WC waist circumference, HC hip circumference
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method for both surgeons and patients. The improved ratio
showed a rising trend according to increasing AHI; however,
the cured ratio showed a downward trend according to in-
creasing AHI, probably because of a higher baseline value of
AHI. The preoperative AHI value was lower in the cured
group, while the mean change in AHI was similar between
the two groups. This might mean that patients with less serious
OSA have more chance to be cured. And, the similar change
of AHI between the cured group and uncured group might be
a comprehensive result, because higher AHI reduction hap-
pens with the increasing preoperative AHI, but the proportion
of more serious OSA at baseline was lower in the cured group.
In contrast, the preoperative AHI values were similar while
the mean changes in AHI differed significantly between the
improved and unimproved groups. Therefore, there might
exist some factors, independent of the effect of LYGB surgery,
which influence the severity of OSA. However, these contents
were not taken into account in the present study.
Weight loss is accompanied by improvements in character-
istics related not only to obesity but also to OSA, suggesting
that weight loss may be a cornerstone of the treatment of both
conditions [24]. However, a relationship between weight re-
duction and OSA remission has not been demonstrated previ-
ously. In our study, the change in AHI after bariatric surgery
was correlated only with preoperative weight, AHI, WC, and
IR index; no relationship was found between the change in
AHI and the change in weight or BMI. In a randomized
controlled study, John et al. reported that bariatric surgery
did not result in a significantly greater reduction in AHI than
conventional weight loss therapy, although the former did
result in more weight loss [25]. They suggested that the state
rather than the extent of weight loss was important in gener-
ating an altered neurohumoral and metabolic-inflammatory
milieu, influencing defects in neuromuscular responses to
mechanical loads [26, 27]. Furthermore, the modified gastro-
intestinal anatomy and physiology may influence the effect of
bariatric surgery on OSA, although no evidence has been
reported to date. Thus, the relationship between weight loss
and OSA needs further investigation.
Several limitations of this study should be recog-
nized. First, the duration of follow-up in our study
was insufficient. Although a sustained effect of LYGB
surgery on weight reduction and OSA improvement has
been reported, more recent studies reported weight re-
gain at 5 years after the operation in 50 % of patients
[28], with therapeutic failure in 7–20 % at 8 years
postoperatively [29]. Thus, modification of OSA
through reduction in weight should be followed with
a long-term plan. Second, we used data from our ob-
servational study, which might have been biased be-
cause it relied on patients volunteering for the second
polysomnography test, although the preoperative data of
the withdrawn group were not significantly different
from those of the follow-up group. Third, our study
could not provide information about the interaction
between bariatric surgery and OSA, due to its simple
design. Thus, the underlying mechanisms should be
assessed in a future study.
Conclusions
Our findings indicate LYGB could result in stable and ade-
quate weight loss for obesity patients with both OSA and
T2DM, and also reinforce LYGB as an effective thera-
peutic intervention in the management of OSA in
Chinese population. Additionally, the preoperative AHI
and age might be important factors that influence the
effort of LYGB. However, the underlying mechanisms require
further study.
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